From: The impact of ATP-binding cassette transporters on metabolic diseases
Drug | Target | Effect | Mechanism | Source | Reference |
---|---|---|---|---|---|
Statins | ABCA1 | Reduce | ↓PI3-K/Akt/FOXO1 & ↓TLR4/ NF-κB | Synthetic | Chen WM et al., 2016 [12] |
Triptolide | ABCA1 | Induce | ↑LPS/TLR4/GPS2 | Natural | Chen J et al., 2014 [41] |
Cilostazol | ABCA1 | Induce | ↑LXR/ABCA1/SREBP-1 | Synthetic | Jeon BH et al., 2015 [94] |
H2S | ABCA1 | Induce | ↑PI3-K/Akt/ PPARα | Synthetic | Li D et al., 2016 [95] |
Paeonol | ABCA1 | Induce | ↓Calpain-related pathway | Natural | Li X et al., 2015 [96] |
Dgn | ABCA1 | Induce | ↓miR-19b expression | Natural | Lv YC et al., 2015 [67] |
Hydrogen | ABCA1 | Induce | Â | Synthetic | Song G et al., 2015 [97] |
Metformin | ABCG5& ABCG8 | Induce | ↑Ldlr ↑AMPK ↓ACLY | Synthetic | Molusky MM et al., 2018 [98] |
CoQ10 | ABCG1 | Induce | ↑Activator protein-1/miR-378/ABCG1 | Natural | Wang D et al., 2014 [99] |
Progesterone | ABCA2 | Induce | ↑mRNA expression | Synthetic& Natural | Davis W et al., 2018 [47] |